Mid-afternoon market update: Dow rises over 100 points, Itamar Medical shares spike higher

Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, dropping 0.07% to 4,455.53.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 40,955,260 cases with around 659,970 deaths. India confirmed a total of at least 33,264,170 cases and 442,870 deaths, while Brazil reported over 20,999,770 COVID-19 cases with 586,850 deaths. In total, there were at least 224,677,810 cases of COVID-19 worldwide with more than 4,630,890 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares gained 2.7% on Monday. Meanwhile, top gainers in the sector included Uranium Royalty Corp. UROY +undefined% (Get Free Alerts for UROY), up 18% and Crescent Point Energy Corp. CPG +undefined% (Get Free Alerts for CPG) up 15%.

In trading on Monday, health care shares fell by 0.8%.

Top Headline

The U.K. government has terminated its COVID-19 vaccine contract with Valneva SE VALN +39.85% over alleged breach of obligations.

Britain has ordered 100 million doses of Valneva's vaccine candidate, VLA2001, and had an option to secure an additional 90 million doses. The total value of these 190 million doses is around €1.4 billion.

Equities Trading UP

Itamar Medical Ltd. ITMR +39.85% shares shot up 45% to $30.25. ZOLL Medical Corporation, an Asahi Kasei company, agreed to acquire Itamar Medical for a total value of approximately $538 million.

Shares of Aterian, Inc. ATER +39.85% got a boost, shooting 41% to $16.58. Investor presentation released on Friday is now circulating on news outlets.

aTyr Pharma, Inc. LIFE +39.85% shares were also up, gaining 48% to $8.13 as the company announced positive results from its Phase 1b/2a trial evaluating its lead therapeutic candidate, ATYR1923, in pulmonary sarcoidosis, a major form of interstitial lung disease.

Equities Trading DOWN

MiMedx Group, Inc. MDXG +59.56% shares tumbled 59% to $6.30 after announcing top-line results from two musculoskeletal trials of micronized dehydrated Human Amnion Chorion Membrane (mdHACM). Top-line results from an interim analysis of the six-month efficacy data for the Phase 2B trial for Knee Osteoarthritis (KOA) did not meet primary endpoints.

Shares of Valneva SE VALN +39.85% were down 40% to $28.06 after the company announced it received a termination notice from the UK Government in relation to the Supply Agreement for its COVID-19 vaccine candidate, VLA2001.

Farmmi, Inc. FAMI +51.3% was down, falling 51% to $0.2821 after the company announced a 368,261,717 share public offering to be priced at $0.22 per share.


In commodity news, oil traded up 0.9% to $70.32, while gold traded up 0.1% to $1,793.40.

Silver traded down 0.7% Monday to $23.74 while copper fell 2% to $4.3610.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 surged 0.29%, the Spanish Ibex Index rose 1.39% and the German DAX 30 climbed 0.59%. Meanwhile, the London’s FTSE 100 rose 0.56%, French CAC 40 gained 0.20% and Italy’s FTSE MIB rose 0.93%.

Wholesale prices in Germany surged 12.3% year-over-year in August, recording the highest rate since October 1974.


The U.S. reported a budget deficit of $171 billion in August, compared to a $200 billion gap in the year-ago period.

Benzinga does not provide investment advice. All rights reserved.

Feed news

How do emotions affect trade?
Follow up our daily analysts guidance

Subscribe Today!    

Latest Forex Analysis

Latest Forex Analysis

Editors’ Picks

EUR/USD drifts down toward 1.17 as mood worsens

EUR/USD is trading closer to 1.17, off the highs. Concerns about Chinese giant Evergrande's troubles return to weigh on sentiment, supporting the safe-haven dollar ahead of the PBOC and Fed meetings on Wednesday. 


GBP/USD falls toward 1.3650 on fresh dollar strength

GBP/USD is retreating back toward 1.3650 as the dollar reasserts itself. Fears that the crisis in China's Evergrande could turn into a more significant downturn have resumed. Central bank decisions are awaited.


Gold: Further advances depend on the Fed

A better market mood put pressure on the American currency. The US Federal Reserve will announce its monetary policy decision on Wednesday. Gold advanced for a second day in a row, but additional gains are in doubt.

Gold News

Alts rebound while Bitcoin tends to its wounds

Bitcoin price suffered a brutal setback as it dropped from being extremely close to a crucial psychological level to slicing through a stable support floor.

Read more

PBoC September Preview: Will policymakers step in to ease Evergrande fears?

People’s Bank of China (PBoC) will announce monetary policy decisions on September 22. Financial markets remain restless amid ongoing Evergrande crisis. PBoC could lower RRR further to support economy. 

Read more